General News

BCI at the 59th ASH Annual Meeting

Posted in General News, Conferences, BCI on the Road Published by Reza Roozitalab 08 December 2017

"The most prestigious event in the haematology calendar"

BCI at the 59th ASH Annual Meeting

Research teams from our Centre for Haemato-Oncology have once again joined the world’s most influential figures in haematology to present their cutting-edge findings at the 59th ASH Annual Meeting & Exposition.

Study sheds new light on how cancer cells adapt to become aggressive

Posted in General News, Publications Published by Reza Roozitalab 04 December 2017

Centrosome amplification: not as clear cut as once thought

Study sheds new light on how cancer cells adapt to become aggressive

A new study from Dr Susana Godinho’s lab has revealed surprising insights into how cancer cells adapt to ‘centrosome amplification’ – a mechanism that they have previously demonstrated to be essential in allowing certain tumours to become aggressive and metastatic.

BCI director Professor Nick Lemoine receives China's highest award for foreign experts

Posted in General News, Grants & Awards Published by Reza Roozitalab 29 November 2017

Professor Lemoine is only the fifth British scientist to have received this honour

BCI director Professor Nick Lemoine receives China's highest award for foreign experts

BCI director Professor Nick Lemoine has been awarded the China Friendship Award - the country’s highest award for ‘foreign experts who have made outstanding contributions to the country's economic and social progress’.

Epigenetic editing: not just a one 'hit' wonder

Posted in General News, Publications Published by Reza Roozitalab 13 November 2017

New research published today in Nature Communications

Epigenetic editing: not just a one 'hit' wonder

For the very first time, researchers at BCI have shown that modifying the ‘epigenome’ of a healthy breast cell is not only possible, but precise enough to initiate a chain reaction of events that make the cell abnormal.

Hugh Brasher and Pancreatic Cancer UK Visit the BCI

Posted in General News, Engagement Published by Reza Roozitalab 10 November 2017

November is Pancreatic Cancer Awareness Month #PCAM

Hugh Brasher and Pancreatic Cancer UK Visit the BCI

Hugh Brasher and members of the team from Pancreatic Cancer UK visited the BCI to learn about the latest research and what is being done to beat pancreatic cancer sooner.

A link between low oxygen "loving" microbes and prostate cancer?

Posted in General News, Publications Published by Reza Roozitalab 09 November 2017

New MALDI-TOF research suggests a link between prostate cancer and low "oxygen" loving bacteria

 A link between low oxygen

Research by Professor Tim Oliver brings to light a possible new link between microbes and prostate cancer, an association that may indicate a radical change in thinking about the causes of the disease.

How Dr Katiuscia Bianchi is using a CRUK Pioneer Award to beat cancer sooner

Posted in General News, Grants & Awards Published by Reza Roozitalab 03 November 2017

A PIONEERING AWARD FOR PIONEERING RESEARCH

How Dr Katiuscia Bianchi is using a CRUK Pioneer Award to beat cancer sooner

With the support of a recent £188,000 Pioneer Award from Cancer Research UK, Dr Katiuscia Bianchi and her team are developing an innovative method to allow researchers to screen and identify new drugs targeting a particular metabolic pathway that cancer cells use to thrive.

Professor Sir Nicholas Wright Awarded Honorary Degree from Imperial College

Posted in General News, Grants & Awards Published by Reza Roozitalab 02 November 2017

Awarded by Imperial College London for outstanding contribution to medicine

Professor Sir Nicholas Wright Awarded Honorary Degree from Imperial College

Professor Sir Nicholas Wright, who leads the Centre for Tumour Biology, has in recognition of his outstanding contribution to medicine, been awarded an honorary doctor of science degree...

A New Target Linked with Several Aggressive Forms of Blood Tumour

Posted in General News, Publications Published by Reza Roozitalab 23 October 2017

Lamin B1 - a potential target for follicular lymphoma and Chronic lymphocytic leukaemia

A New Target Linked with Several Aggressive Forms of Blood Tumour

Manipulating levels of Lamin B1 may one day prove an effective treatment option for patients with lymphomas and chronic lymphocytic leukaemia...

RECRUITING: ATOMIC-meso, a Global Randomised Trial of Triplet Drug Therapy for Malignant Mesothelioma

Posted in General News Published by Reza Roozitalab 19 October 2017

ADI-PEG20 continues to show promise

RECRUITING: ATOMIC-meso, a Global Randomised Trial of Triplet Drug Therapy for Malignant Mesothelioma

Several ongoing clinical trials, led by Dr Peter Szlosarek at the Barts Cancer Centre, continue to investigate the clinical efficacy of "arginine starvation" using ADI-PEG20...

[12 3 4  >>  
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.